Biocartis introduces new Idylla assay for gene fusion testing
Molecular diagnostics firm Biocartis has launched Idylla GeneFusion Assay as a rapid lab workflow solution for gene fusion testing.

Molecular diagnostics firm Biocartis has launched Idylla GeneFusion Assay as a rapid lab workflow solution for gene fusion testing.
The US Food and Drug Administration (FDA) has granted marketing authorisation to BioFire Diagnostics’ SARS-CoV-2 test.
GenScript Biotech’s subsidiary GenScript Biotech Singapore has signed an agreement with UAE’s G42 Healthcare for exploring new solutions to…
PerkinElmer’s subsidiary EUROIMMUN has introduced the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope with EUROLabOffice 4.0 (ELO 4.0) software…
Researchers at the University of Rhode Island (URI) in the US have developed a saliva-based test to detect the…
MicroPort Orthopedics has announced that it witnessed increased adoption of its Kinematic Alignment (KA) approach for the Evolution Medial-Pivot…
Roche has launched new SARS-CoV-2 research use only laboratory test to help monitor emerging mutations of coronavirus.
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Olympus’ Narrow Band Imaging (NBI) to assess…
Fujifilm Europe has launched its rapid antigen test kit for the detection of SARS-CoV-2 infection, following the receipt of…
Thank you for subscribing to Medical Device Network